BRAIN Biotech AG
About BRAIN Biotech AG
Categories
-
Country/Region:Germany
-
On CPHI since:2024
-
Employees:250 - 499
Company types
Primary activities
Products from BRAIN Biotech AG (2)
-
Product Enzymes, Enzyme products, and Enzyme Expression Services
The BRAIN Biotech Group’s proprietary bioarchive offers access to an immense variety of new biological solutions for sustainable industrial processes and ingredients. The BRAIN BioArchive encompasses microorganisms, natural compounds, fractions obtained from edible plant material, proprietary metagenome an... -
Product Microbial Strains and Strain Engineering
Our BRAIN Bioarchive provides access to a wealth of new biological solutions for industrial processes and applications. Whether the aim is to utilize different substrates (including CO2), develop novel or alternative biosynthetic products and more stable production strains, identify safe strains and microo...
BRAIN Biotech AG Resources (1)
-
News BRAIN Biotech AG announces the appointment of Erik de Vries as Senior Business Development Director Enzymes
BRAIN Biotech AG and Enzymicals AG are pleased to announce that Dr. Erik de Vries will join BRAIN Biotech as Senior Business Development Director Enzymes as of June 1st, 2024. De Vries will continue in his current position as CEO of Enzymicals AG on a part-time basis during a transition phase until the end of the year. During this transition phase, his activities will already focus on BRAIN Biotech at the Zwingenberg site.